Microbot Medical Inc.
Income Statement
| Line Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|
| Revenue | $116.9K | $1.0M | $172.3K | $1.4M | $1.2M | $1.4M | $992.9K |
| Cost of Revenue | — | — | $316.6K | $263.2K | $214.8K | $168.4K | $261.4K |
| Gross Profit | — | — | $886.6K | $1.1M | $1.0M | $1.3M | $731.4K |
| Gross Margin | — | — | 514.6% | 80.8% | 82.4% | 88.2% | 73.7% |
| Operating Expenses | |||||||
| Research & Development | $-823.0K | $21.5M | $19.4M | $14.7M | $19.9M | $21.0M | $19.9M |
| SG&A Expense | $-92.0K | $10.4M | $8.8M | $7.4M | $8.2M | $9.4M | $9.5M |
| Operating Income | $915.0K | $-30.9M | $-28.1M | $-21.9M | $-28.1M | $-29.4M | $-29.4M |
| Operating Margin | 782.8% | -3,053.2% | -16,304.8% | -1,601.5% | -2,300.1% | -2,057.5% | -2,958.9% |
| Interest Expense | $6.0K | $1.3M | $1.2M | $50.2K | $71.4K | $93.4K | $110.8K |
| Pretax Income | $36.4M | $32.7M | $26.4M | $28.5M | $21.3M | — | — |
| Income Tax Expense | — | — | — | — | — | — | — |
| Net Income | $-921.0K | $-32.7M | $-26.4M | $-28.5M | $-21.3M | $-25.2M | $-27.0M |
| Net Margin | -787.9% | -3,234.1% | -15,345.1% | -2,082.8% | -1,747.3% | -1,769.0% | -2,722.0% |
| EPS (Basic) | $0.01 | $-0.18 | $-0.20 | $-0.33 | $-0.50 | $-0.68 | $-0.85 |
| EPS (Diluted) | $0.01 | $-0.18 | $-0.20 | $-0.33 | $-0.50 | $-0.68 | $-0.85 |
| Shares Outstanding (Basic) | 39.5M | 206.2M | 165.4M | 112.5M | 67.3M | 38.2M | — |
| Shares Outstanding (Diluted) | 39.5M | 206.2M | 165.4M | 112.5M | 67.3M | 38.2M | — |
| Dividends Per Share | — | — | — | — | — | — | — |